SFM
KYMR icon

Sphera Funds Management’s Kymera Therapeutics KYMR Stock Holding History

Sphera Funds Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-368,061
Closed -$15.6M – 69
2022
Q1 		$15.6M Buy
368,061
+49,394
+16% +$2.09M 2.2% 15
2021
Q4 		$20.2M Sell
318,667
-40,593
-11% -$2.36M 2.22% 11
2021
Q3 		$21.1M Buy
359,260
+99,365
+38% +$5.76M 1.77% 11
2021
Q2 		$12.6M Buy
259,895
+12,368
+5% +$537K 0.85% 33
2021
Q1 		$9.62M Buy
247,527
+99,827
+68% +$6.01M 0.74% 31
2020
Q4 		$9.16M Sell
147,700
-12,300
-8% -$600K 0.81% 35
2020
Q3 		$5.17M Buy
+160,000
New +$4.88M 0.51% 59

Other funds holding KYMR

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Sphera Funds Management's KYMR Position: Q2 2022 in Review

Sphera Funds Management sold out of Kymera Therapeutics (KYMR) in Q2 2022, closing a stake of 368,061 shares — an estimated $15.6M sold.

Sphera Funds Management first reported a position in KYMR in Q3 2020 and held it in 7 quarters. The position peaked at $21.1M in Q3 2021. 100 funds tracked by Wall St. Rank hold KYMR as of Q2 2022.

  • Sphera Funds Management reported no remaining Kymera Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Sphera Funds Management sold 368,061 Kymera Therapeutics shares in Q2 2022, an estimated $15.6M.
  • Sphera Funds Management first reported a position in Kymera Therapeutics in Q3 2020 and held it in 7 quarters.
  • Sphera Funds Management's Kymera Therapeutics position peaked at $21.1M in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2022.

Based on Sphera Funds Management's 13F filing for Q2 2022, filed 15 Aug 2022.